That's a great idea bud, [after all the ASX index can be tweaked...

  1. 2,629 Posts.
    lightbulb Created with Sketch. 396
    That's a great idea bud, [after all the ASX index can be tweaked to periodically remove dog stocks so the index only have positive stocks], but jokes aside, yes thanks, I have done that as below and will continue from tomorrow by having returns excluding lottery stocks and another with lottery stocks weighted 1/4 of core stocks. That said, I am not here to give any advice on sizing other than generally saying that lottery stocks are just that- you don't spend $10k buying lottery tickets, if you are destined for riches, the lottery will find you with a single lottery ticket.

    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7
    0   OPPORTUNITY STOCKS Date stock mentioned in Its Over thread Open price on date stock mentioned 16/7/19 close Change% Potential Upside
    1 1 XRO [XERO] [closed] 11/2/19 $ 46.200 $ 53.600 16.0% Phase 3-4 ; growth & getting in profitability
    2 2 MYE [MASTERMYNE] [closed] 11/2/19 $ 0.840 $ 0.820 -2.4% Phase 4- growth
    3 3 CLV [CLOVER] [closed] 11/2/19 $ 1.525 $ 2.130 39.7% Phase 4- growth
    4 4 SFC [SCHAEFFER] [closed] 12/2/19 $ 14.480 $ 14.200 -1.9% Phase 4-growth
    5 5 YOW [YOWIE] [closed] 19/2/19 $ 0.070 $ 0.090 28.6% Phase 3-validated; shareholder conflict
    6 6 CAT [CATAPULT] [closed] 21/2/19 $ 0.640 $ 0.840 31.3% Phase 3-validated; governance issue
    7 7 PME [PROMEDICUS] [closed] 21/2/19 $ 14.45 $ 19.95 38.1% Phase 4-growth
    8 8 VHT [VOLPARA] 6/3/19 $ 1.147 $ 1.660 44.8% Phase 2-3 -validating & ramping
    9 9 NST [NORTHERN STAR] 8/3/19 $ 8.87 $ 12.11 36.5% Phase 4- defensive growth
    10 10 ANO [ADVANCED NANOTEK] [closed] 8/3/19 $ 3.05 $ 5.00 63.9% Phase 4-growth
    11 11 CYL [CATALYST METALS] 13/3/19 $ 2.30 $ 2.07 -10.0% Phase 1-positive discovery
    12 12 NUH [NUHEARA] [closed] 13/3/19 $ 0.069 $ 0.061 -11.6% Phase 1-2 nearing validation; governance issue
    13 13 MWY [MIDWAY] 14/3/19 $ 3.980 $ 3.500 -12.1% Phase 4- growth
    14 14 D20 [DUXTON WATER] 27/3/19 $ 1.530 $ 1.450 -5.2% Phase 4-defensive growth & scalability
    15 15 PNV [POLYNOVO] 1/4/19 $ 0.760 $ 1.580 107.9% Phase 2-3- validated & ramping & getting into profitability
    16 16 DUB [DUBBER] 8/4/19 $ 0.925 $ 1.310 41.6% Phase 2-3- validated & ramping
    17 17 TTT [TITOMIC] 8/4/19 $ 2.300 $ 1.940 -15.7% Phase 1-positive discovery
    18 18 EVS [ENVIROSUITE] 10/4/19 $ 0.170 $ 0.125 -26.5% Phase 2-3- validated & ramping
    19 19 AD8 [AUDINATE] 10/4/19 $ 6.290 $ 7.880 25.3% Phase 3- validated, ramping into profitable growth
    20 20 TNY [TINY BEANS] 23/4/19 $ 0.605 $ 1.230 103.3% Phase 2-3- validated & ramping & getting into profitability
    21 21 MVP [MEDICAL DEV ITNL] 26/4/19 $ 5.450 $ 6.100 11.9% Phase 3-4-growth
    22 22 STG [STRAKER TRANSLATIONS] 29/4/19 $ 1.580 $ 1.960 24.1% Phase 2-3- validated & ramping & getting into profitability
    23 23 PPS [PRAEMIUM] 21/5/19 $ 0.400 $ 0.470 17.5% Re-rating opportunity from an oversold position
    24 24 NXS [NEXT SCIENCE] 22/5/19 $ 2.400 $ 3.810 58.8% Phase 2- validated & just started growth phase [significant potential]
    25 25 BLACK CAT SYND [BC8] 22/5/19 $ 0.295 $ 0.330 11.9% Phase 1- positive discovery
    26 26 I SIGN THIS [ISX] 27/5/19 $ 0.645 $ 0.670 3.9% Phase 2-3- validated & ramping & getting into profitability
    27 27 PROTEOMICS [PIQ] 4/6/19 $ 0.275 $ 0.330 20.0% Phase 1- positive validated IP , awaiting business development catalyst for a substantial re-rate
    28 28 ANO [ADVANCED NANOTEK] 12/6/19 $ 6.09 $ 4.720 -22.5% Phase 4-growth
    29 29 CLV [CLOVER] 13/6/19 $ 1.875 $ 2.080 10.9% Phase 4- growth
    30 30 AMS [ATOMOS] 1/7/19 $ 1.080 $ 1.380 27.8% Phase 3- growth, ebitda positive high growth high margin business
    31 31 OEC [ORBITAL CORP] 4/7/19 $ 0.350 $ 0.325 -7.1% Undervalued $25m company that has secured a min $120m 5 year contract with Boeing subsidiary
    32   COMPOSITE RETURN% ex Lottery Stocks       20.9%  
    33   LOTTERY STOCKS          
    34 32 4DS [4DS] [closed] 20/2/19 $ 0.067 $ 0.076 13.4% Phase 1-positive discovery
    35 33 BIT [BIOTRON] 20/2/19 $ 0.090 $ 0.084 -6.7% Phase 1-positive discovery
    36 34 ACW [ACTINOGEN] [closed] 20/2/19 $ 0.054 $ 0.014 -74.1% Failed to demonstrate cognitive improvement
    37 35 LOM [LUCAPA DIAMOND] 31/5/19 $ 0.150 $ 0.160 6.7% Undervalued and a spec punt for Lulo mother load find
    38   COMPOSITE RETURN% incl Lottery Stocks at 1/4 weighting of Core Stocks       19.8%  
    39   SMALL CAP ORDS RETURN% SINCE 11/2/19       8.1%  
    40   SUPPLEMENTARY STOCK          
    41 S-1 AER [AERRIS] 2/5/19 $ 0.100 $ 0.140 40.0% Phase 2- $6m penny stock / validated
    42 S-2 LBT [LBT INNOVATIONS] 28/6/19 $ 0.120 $ 0.120 0.0% Product FDA validated $28m market cap
    43 S-3 UUV [AQUABOTIX] 3/7/19 $ 0.008 $ 0.007 -12.5% US Defence endorsed Swarm robotic drone IP tech for <$3m!
    44   COMPOSITE RETURN% incl Lottery Stocks+Supplementary Stocks at 1/4 weighting of Core Stocks       19.6%  
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.